These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17602084)

  • 1. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study.
    Gershenson DM; Miller AM; Champion VL; Monahan PO; Zhao Q; Cella D; Williams SD;
    J Clin Oncol; 2007 Jul; 25(19):2792-7. PubMed ID: 17602084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors.
    Zanagnolo V; Sartori E; Trussardi E; Pasinetti B; Maggino T
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):235-43. PubMed ID: 15921842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life after among ovarian germ cell cancer survivors: a narrative analysis.
    Swenson MM; MacLeod JS; Williams SD; Miller AM; Champion VL
    Oncol Nurs Forum; 2003; 30(3):380. PubMed ID: 12719752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study.
    Greimel ER; Winter R; Kapp KS; Haas J
    Psychooncology; 2009 May; 18(5):476-82. PubMed ID: 18702067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do male lymphoma survivors have impaired sexual function?
    Kiserud CE; Schover LR; Dahl AA; Fosså A; Bjøro T; Loge JH; Holte H; Yuan Y; Fosså SD
    J Clin Oncol; 2009 Dec; 27(35):6019-26. PubMed ID: 19858388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".
    Solheim O; Tropé CG; Rokkones E; Kærn J; Paulsen T; Salvesen HB; Hagen B; Vereide AB; Fosså SD
    Gynecol Oncol; 2015 Feb; 136(2):224-9. PubMed ID: 25511159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy.
    Lackner JE; Koller A; Schatzl G; Marberger M; Kratzik C
    Urology; 2009 Oct; 74(4):825-9. PubMed ID: 19589582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
    Bishop MM; Beaumont JL; Hahn EA; Cella D; Andrykowski MA; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
    J Clin Oncol; 2007 Apr; 25(11):1403-11. PubMed ID: 17416860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage.
    de Vos FY; Nuver J; Willemse PH; van der Zee AG; Messerschmidt J; Burgerhof JG; de Vries EG; Gietema JA
    Eur J Cancer; 2004 Mar; 40(5):696-700. PubMed ID: 15010070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and sexual functioning in cervical cancer survivors.
    Frumovitz M; Sun CC; Schover LR; Munsell MF; Jhingran A; Wharton JT; Eifel P; Bevers TB; Levenback CF; Gershenson DM; Bodurka DC
    J Clin Oncol; 2005 Oct; 23(30):7428-36. PubMed ID: 16234510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors associated with quality of life in survivors of gestational trophoblastic neoplasm after chemotherapy].
    Quan MY; Xiang Y; Wan XR; Feng FZ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):673-6. PubMed ID: 21092547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility.
    Schover LR
    J Clin Oncol; 2008 Feb; 26(5):753-8. PubMed ID: 18258983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ cell tumors of the ovary.
    Pectasides D; Pectasides E; Kassanos D
    Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects on sexual function and fertility after treatment of testicular cancer.
    Hartmann JT; Albrecht C; Schmoll HJ; Kuczyk MA; Kollmannsberger C; Bokemeyer C
    Br J Cancer; 1999 May; 80(5-6):801-7. PubMed ID: 10360658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.
    Tan DS; Rothermundt C; Thomas K; Bancroft E; Eeles R; Shanley S; Ardern-Jones A; Norman A; Kaye SB; Gore ME
    J Clin Oncol; 2008 Dec; 26(34):5530-6. PubMed ID: 18955455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
    Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
    Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.